Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|November 28, 2000
Epidermal growth factor sensitizes cells to ionizing radiation by down-regulating protein mutated in ataxia-telangiectasiaN Gueven, K E Keating, P Chen, et al.
World Journal of Gastroenterology|May 31, 2016
Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patientsY D Wu, D N Zhou, Y Q Gang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 21, 1998
Reduced interferon gamma production by antigen-stimulated cord blood mononuclear cells is a risk factor of allergic disorders--6-year follow-up studyN Kondo, Y Kobayashi, S Shinoda, et al.
Zhonghua Yi Xue Za Zhi|October 21, 2016
[Cognitive effectiveness of risperidone and olanzapine in first-episode schizophrenia]J Zhao, Y Zhang, Y Y Chao, et al.
Human Mutation|January 1, 1995
Molecular, biochemical, and clinical characterization of mitochondrial acetoacetyl-coenzyme A thiolase deficiency in two further patientsA Wakazono, T Fukao, S Yamaguchi, et al.
International Journal of Cancer|December 20, 1996
Microsatellite instability in B-cell lymphoma originating from Bloom syndromeH Kaneko, R Inoue, Y Yamada, et al.
Biochemical and Biophysical Research Communications|December 16, 1991
Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfataseS Tomatsu, S Fukuda, M Masue, et al.
Genomics|June 15, 1996
Comparative genome mapping of the ataxia-telangiectasia region in mouse, rat, and Syrian hamsterY Matsuda, T Imai, T Shiomi, et al.
Human Molecular Genetics|May 18, 2000
Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypesK Sukegawa, H Nakamura, Z Kato, et al.
Pediatric Hematology and Oncology|October 23, 1998
Ataxia telangiectasia associated with B-cell lymphoma: the effect of a half-dose of the drugs administered according to the acute lymphoblastic leukemia standard risk protocolY Yamada, R Inoue, T Fukao, et al.
Pageof 14